{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:09:49Z","timestamp":1789675789692,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Holding SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003122","name":"Ferring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003122","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajog.2026.05.019","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:20:13Z","timestamp":1780118413000},"page":"974-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antihuman leukocyte antigen antibodies and risk of fetal growth restriction"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2636-0628","authenticated-orcid":false,"given":"Pierre","family":"Hannoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Verdoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Jollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Taupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bonneaudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Th\u00e9venin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiae","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Benachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Lafarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2026.05.019_bib1","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/AOG.0000000000004251","article-title":"Fetal growth restriction: ACOG practice bulletin, number 227","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.05.019_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13522","article-title":"FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction","volume":"152","author":"Melamed","year":"2021","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2026.05.019_bib3","first-page":"533","article-title":"An immunologic basis for placental insufficiency in fetal growth restriction","volume":"29","author":"Greer","year":"2012","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2026.05.019_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103438","article-title":"Chronic Villitis of unknown etiology (VUE): obstetrical features, outcome and treatment","volume":"148","author":"Mekinian","year":"2021","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2026.05.019_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.placenta.2013.07.003","article-title":"Investigating the association of villitis of unknown etiology with stillbirth and fetal growth restriction \u2013 a systematic review","volume":"34","author":"Derricott","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2026.05.019_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.humpath.2007.05.025","article-title":"Villitis of unknown etiology: noninfectious chronic Villitis in the placenta","volume":"38","author":"Redline","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2026.05.019_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.placenta.2024.06.020","article-title":"Placental chronic inflammatory histopathology and fetal growth in a cohort with universal placental examination","volume":"154","author":"Salafia","year":"2024","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2026.05.019_bib8","doi-asserted-by":"crossref","first-page":"662.e1","DOI":"10.1016\/j.ajog.2021.06.051","article-title":"Chronic histiocytic intervillositis: manifestation of placental alloantibody-mediated rejection","volume":"225","author":"Benachi","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.05.019_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.placenta.2010.11.021","article-title":"Chronic histiocytic intervillositis of unknown etiology: clinical features in a consecutive series of 69 cases","volume":"32","author":"Marchaudon","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2026.05.019_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.placenta.2020.07.032","article-title":"Chronic Intervillositis of Unknown Etiology (CIUE): prevalence, patterns and reproductive outcomes at a tertiary referral institution","volume":"100","author":"Simula","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2026.05.019_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/aji.12143","article-title":"Maternal floor infarction\/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection","volume":"70","author":"Romero","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2026.05.019_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2350\/14-12-1582-OA.1","article-title":"Significance of C4d immunostaining in placental chronic intervillositis","volume":"18","author":"Bendon","year":"2015","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.ajog.2026.05.019_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13373","article-title":"Chronic histiocytic intervillositis: a breakdown in immune tolerance comparable to allograft rejection?","volume":"85","author":"Brady","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2026.05.019_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/10935266231176682","article-title":"C4d staining is present in normal placentas from pregnancies prior to pregnancy loss associated with chronic histiocytic intervillositis and is reduced by immunomodulatory therapy in subsequent pregnancies","volume":"26","author":"Chan","year":"2023","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.ajog.2026.05.019_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/10935266221144083","article-title":"Patterns of interferon \u03b3 expression and C4d deposition in chronic intervillositis of unknown etiology","volume":"26","author":"Terry","year":"2023","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.ajog.2026.05.019_bib16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s43032-019-00101-9","article-title":"Upregulation of HLA-class I and II in placentas diagnosed with Villitis of unknown etiology","volume":"27","author":"Enninga","year":"2020","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2026.05.019_bib17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2026.05.019_bib18","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.ajog.2026.05.019_bib19","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/j.1537-2995.2008.01810.x","article-title":"The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review","volume":"48","author":"Middelburg","year":"2008","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.ajog.2026.05.019_bib20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0897.2011.01066.x","article-title":"Maternal HLA panel reactive antibodies in early gestation positively correlates with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection","volume":"66","author":"Lee","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2026.05.019_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1365-2559.2011.04038.x","article-title":"Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies","volume":"59","author":"Lee","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.ajog.2026.05.019_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/aji.12141","article-title":"Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk for antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery","volume":"70","author":"Lee","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2026.05.019_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jri.2016.03.003","article-title":"HLA-C antibodies in women with recurrent miscarriage suggests that antibody mediated rejection is one of the mechanisms leading to recurrent miscarriage","volume":"116","author":"Meuleman","year":"2016","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2026.05.019_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jgyn.2015.08.009","article-title":"Courbes de croissance in utero ajust\u00e9es et non ajust\u00e9es adapt\u00e9es \u00e0 la population fran\u00e7aise. I \u2013 m\u00e9thodes de construction","volume":"45","author":"Ego","year":"2016","journal-title":"J Gyn\u00e9cologie Obst\u00e9trique Biol Reprod"},{"key":"10.1016\/j.ajog.2026.05.019_bib25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/ajt.12048","article-title":"Frequency and determinants of pregnancy-induced child-specific sensitization","volume":"13","author":"H\u00f6nger","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajog.2026.05.019_bib26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.humimm.2013.04.025","article-title":"Incidence and risk factors of anti-HLA immunization after pregnancy","volume":"74","author":"Masson","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ajog.2026.05.019_bib27","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1537-2995.2009.02206.x","article-title":"The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy","volume":"49","author":"Triulzi","year":"2009","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.ajog.2026.05.019_bib28","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/01.TP.0000120385.03278.28","article-title":"The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens","volume":"77","author":"Dankers","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.ajog.2026.05.019_bib29","article-title":"A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2026.05.019_bib30","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.05.019_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3109\/14767050903216033","article-title":"Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia","volume":"23","author":"Ogg\u00e9","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2026.05.019_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.05.019_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2026.05.019_bib34","article-title":"Immune tolerance breakdown in pregnancy: transplantation parallels in chronic intervillositis and villitis of unknown etiology","author":"Hannoun","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.05.019_bib35","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ajog.2015.08.041","article-title":"Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance","volume":"213","author":"Kim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.05.019_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101527","article-title":"Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: a double-blind, randomised, placebo-controlled trial","volume":"50","author":"Yamada","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ajog.2026.05.019_bib37","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ajog.2005.06.043","article-title":"Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy","volume":"193","author":"Althaus","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.05.019_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13898","article-title":"Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies","volume":"92","author":"Abisror","year":"2024","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2026.05.019_bib39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa2314466","article-title":"Nipocalimab in early-onset severe hemolytic disease of the fetus and newborn","volume":"391","author":"Moise","year":"2024","journal-title":"N Engl J Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:31:25Z","timestamp":1789673485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937826002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0002937826002929"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2026.05.019","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihuman leukocyte antigen antibodies and risk of fetal growth restriction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2026.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}